Mizuho Securities Reiterates Buy Rating on Evolus (EOLS) Following 3Q Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. LDOS
8. AXP
9. HUM
10. CSCO

Go back to Mizuho Securities Reiterates Buy Rating on Evolus (EOLS) Following 3Q Beat

Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update

November 4, 2019 7:00 AM EST

Jeuveau® Generated $13.2 Million in U.S. Net Revenue in Q3 2019; up from $2.3 Million in Q2 2019

J.E.T. Enrolled Accounts Drove 90% of Q3 Revenue

Jeuveau® Achieved Number Three Unit Share Position in the U.S. for Q3 20191

Nuceiva Approved in the European Union and Launched in Canada

NEWPORT BEACH, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today... More